CRP and cancer: There is increasing evidence that the presence of a systemic inflammatory response, as evidenced by elevated concentrations of C-reactive protein, is a prognostic factor independent of stage, performance status and weight loss in patients with advanced cancer (O’Gorman et al, 2000; Scott et al, 2002; Maltoni et al, 2005).